[1]
Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America Project. Prevalence of kidney stones in the United States. European urology. 2012 Jul:62(1):160-5. doi: 10.1016/j.eururo.2012.03.052. Epub 2012 Mar 31
[PubMed PMID: 22498635]
[2]
Reesink DJ, Scheltema JMW, Barendrecht MM, Boeken Kruger AE, Jansonius A, Wiltink J, van der Windt F. Extracorporeal shock wave lithotripsy under intravenous sedation for treatment of urolithiasis. Scandinavian journal of urology. 2018 Oct-Dec:52(5-6):453-458. doi: 10.1080/21681805.2018.1524398. Epub 2018 Nov 18
[PubMed PMID: 30451054]
[3]
York NE, Zheng M, Elmansy HM, Rivera ME, Krambeck AE, Lingeman JE. Stone-free Outcomes of Flexible Ureteroscopy for Renal Calculi Utilizing Computed Tomography Imaging. Urology. 2019 Feb:124():52-56. doi: 10.1016/j.urology.2018.09.005. Epub 2018 Nov 2
[PubMed PMID: 30391680]
[4]
Suliman A, Burki T, Garriboli M, Glass J, Taghizadeh A. Flexible ureterorenoscopy to treat upper urinary tract stones in children. Urolithiasis. 2020 Feb:48(1):57-61. doi: 10.1007/s00240-018-1083-5. Epub 2018 Oct 28
[PubMed PMID: 30370467]
[6]
Kachkoul R, Touimi GB, El Mouhri G, El Habbani R, Mohim M, Lahrichi A. Urolithiasis: History, epidemiology, aetiologic factors and management. The Malaysian journal of pathology. 2023 Dec:45(3):333-352
[PubMed PMID: 38155376]
[7]
Bowen DK, Tasian GE. Pediatric Stone Disease. The Urologic clinics of North America. 2018 Nov:45(4):539-550. doi: 10.1016/j.ucl.2018.06.002. Epub 2018 Sep 7
[PubMed PMID: 30316309]
[8]
Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. European journal of epidemiology. 2018 Nov:33(11):1033-1047. doi: 10.1007/s10654-018-0426-4. Epub 2018 Jul 31
[PubMed PMID: 30066054]
Level 1 (high-level) evidence
[16]
Stamatelou K, Goldfarb DS. Epidemiology of Kidney Stones. Healthcare (Basel, Switzerland). 2023 Feb 2:11(3):. doi: 10.3390/healthcare11030424. Epub 2023 Feb 2
[PubMed PMID: 36766999]
[17]
Daudon M, Frochot V, Bazin D, Jungers P. Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment. Drugs. 2018 Feb:78(2):163-201. doi: 10.1007/s40265-017-0853-7. Epub
[PubMed PMID: 29264783]
[18]
Izzedine H, Lescure FX, Bonnet F. HIV medication-based urolithiasis. Clinical kidney journal. 2014 Apr:7(2):121-6. doi: 10.1093/ckj/sfu008. Epub 2014 Mar 11
[PubMed PMID: 25852859]
[19]
Sighinolfi MC, Eissa A, Bevilacqua L, Zoeir A, Ciarlariello S, Morini E, Puliatti S, Durante V, Ceccarelli PL, Micali S, Bianchi G, Rocco B. Drug-Induced Urolithiasis in Pediatric Patients. Paediatric drugs. 2019 Oct:21(5):323-344. doi: 10.1007/s40272-019-00355-5. Epub
[PubMed PMID: 31541411]
[20]
Bennett S, Hoffman N, Monga M. Ephedrine- and guaifenesin-induced nephrolithiasis. Journal of alternative and complementary medicine (New York, N.Y.). 2004 Dec:10(6):967-9
[PubMed PMID: 15673990]
[22]
Carr MC, Prien EL Jr, Babayan RK. Triamterene nephrolithiasis: renewed attention is warranted. The Journal of urology. 1990 Dec:144(6):1339-40
[PubMed PMID: 2231920]
[23]
Roedel MM, Nakada SY, Penniston KL. Sulfamethoxazole-induced sulfamethoxazole urolithiasis: a case report. BMC urology. 2021 Sep 17:21(1):133. doi: 10.1186/s12894-021-00894-5. Epub 2021 Sep 17
[PubMed PMID: 34535099]
Level 3 (low-level) evidence
[24]
Unno R, Taguchi K, Hosier G, Usawachintachit M, Sui W, Yang H, Hamouche F, Bayne D, Stoller M, Chi T. Maternal family history of urolithiasis is associated with earlier age of onset of stone disease. World journal of urology. 2023 Jan:41(1):241-247. doi: 10.1007/s00345-022-04221-x. Epub 2022 Dec 11
[PubMed PMID: 36504337]
[25]
Kocvara R, Plasgura P, Petrík A, Louzenský G, Bartonícková K, Dvorácek J. A prospective study of nonmedical prophylaxis after a first kidney stone. BJU international. 1999 Sep:84(4):393-8
[PubMed PMID: 10468751]
[26]
Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney international. 2004 Feb:65(2):386-92
[PubMed PMID: 14717908]
[28]
Lotan Y, Antonelli J, Jiménez IB, Gharbi H, Herring R, Beaver A, Dennis A, Von Merveldt D, Carter S, Cohen A, Poindexter J, Moe OW, Pearle MS. The kidney stone and increased water intake trial in steel workers: results from a pilot study. Urolithiasis. 2017 Apr:45(2):177-183. doi: 10.1007/s00240-016-0892-7. Epub 2016 May 26
[PubMed PMID: 27228999]
Level 3 (low-level) evidence
[29]
Wang JS, Chiang HY, Chen HL, Flores M, Navas-Acien A, Kuo CC. Association of water intake and hydration status with risk of kidney stone formation based on NHANES 2009-2012 cycles. Public health nutrition. 2022 Sep:25(9):2403-2414. doi: 10.1017/S1368980022001033. Epub 2022 May 6
[PubMed PMID: 35514256]
[30]
Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and other beverages and the risk of kidney stones. Clinical journal of the American Society of Nephrology : CJASN. 2013 Aug:8(8):1389-95. doi: 10.2215/CJN.11661112. Epub 2013 May 15
[PubMed PMID: 23676355]
[31]
Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. American journal of epidemiology. 1996 Feb 1:143(3):240-7
[PubMed PMID: 8561157]
[32]
Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Annals of internal medicine. 1998 Apr 1:128(7):534-40
[PubMed PMID: 9518397]
[33]
Littlejohns TJ, Neal NL, Bradbury KE, Heers H, Allen NE, Turney BW. Fluid Intake and Dietary Factors and the Risk of Incident Kidney Stones in UK Biobank: A Population-based Prospective Cohort Study. European urology focus. 2020 Jul 15:6(4):752-761. doi: 10.1016/j.euf.2019.05.002. Epub 2019 May 10
[PubMed PMID: 31085062]
[34]
Yuan S, Larsson SC. Coffee and Caffeine Consumption and Risk of Kidney Stones: A Mendelian Randomization Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2022 Jan:79(1):9-14.e1. doi: 10.1053/j.ajkd.2021.04.018. Epub 2021 Oct 21
[PubMed PMID: 34690004]
[35]
Ferraro PM, Curhan GC. More Good News: Coffee Prevents Kidney Stones. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2022 Jan:79(1):3-4. doi: 10.1053/j.ajkd.2021.07.002. Epub 2021 Oct 21
[PubMed PMID: 34690003]
[36]
Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CY, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of urology. 2005 Aug:174(2):590-4; quiz 801
[PubMed PMID: 16006907]
[37]
Sorensen MD, Hsi RS, Chi T, Shara N, Wactawski-Wende J, Kahn AJ, Wang H, Hou L, Stoller ML, Women’s Health Initiative Writing Group. Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women's Health Initiative report. The Journal of urology. 2014 Dec:192(6):1694-9. doi: 10.1016/j.juro.2014.05.086. Epub 2014 May 22
[PubMed PMID: 24859445]
[38]
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. The New England journal of medicine. 1993 Mar 25:328(12):833-8
[PubMed PMID: 8441427]
[39]
Sorensen MD, Kahn AJ, Reiner AP, Tseng TY, Shikany JM, Wallace RB, Chi T, Wactawski-Wende J, Jackson RD, O'Sullivan MJ, Sadetsky N, Stoller ML, WHI Working Group. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. The Journal of urology. 2012 May:187(5):1645-9. doi: 10.1016/j.juro.2011.12.077. Epub 2012 Mar 14
[PubMed PMID: 22425103]
[40]
Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. Journal of the American Society of Nephrology : JASN. 2009 Oct:20(10):2253-9. doi: 10.1681/ASN.2009030276. Epub 2009 Aug 13
[PubMed PMID: 19679672]
[41]
Chewcharat A, Curhan G. Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis. 2021 Feb:49(1):27-39. doi: 10.1007/s00240-020-01210-w. Epub 2020 Sep 1
[PubMed PMID: 32870387]
[42]
Young BJ, Tejwani R, Wang HH, Wolf S, Purves JT, Wiener JS, Routh JC. Is the Economic Impact and Utilization of Imaging Studies for Pediatric Urolithiasis Across the United States Increasing? Urology. 2016 Aug:94():208-13. doi: 10.1016/j.urology.2016.05.019. Epub 2016 May 18
[PubMed PMID: 27208819]
[43]
Soucie JM,Thun MJ,Coates RJ,McClellan W,Austin H, Demographic and geographic variability of kidney stones in the United States. Kidney international. 1994 Sep;
[PubMed PMID: 7996811]
[44]
Jobs K, Rakowska M, Paturej A. Urolithiasis in the pediatric population - current opinion on epidemiology, patophysiology, diagnostic evaluation and treatment. Developmental period medicine. 2018:22(2):201-208
[PubMed PMID: 30056408]
Level 3 (low-level) evidence
[45]
Bauza JL, Pieras EC, Grases F, Tubau V, Guimerà J, Sabaté XA, Pizà P. Urinary tract infection's etiopathogenic role in nephrolithiasis formation. Medical hypotheses. 2018 Sep:118():34-35. doi: 10.1016/j.mehy.2018.06.002. Epub 2018 Jun 5
[PubMed PMID: 30037611]
[47]
Moftakhar L, Jafari F, Ghoddusi Johari M, Rezaeianzadeh R, Hosseini SV, Rezaianzadeh A. Prevalence and risk factors of kidney stone disease in population aged 40-70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran. BMC urology. 2022 Dec 19:22(1):205. doi: 10.1186/s12894-022-01161-x. Epub 2022 Dec 19
[PubMed PMID: 36536352]
Level 2 (mid-level) evidence
[48]
Shoag J,Tasian GE,Goldfarb DS,Eisner BH, The new epidemiology of nephrolithiasis. Advances in chronic kidney disease. 2015 Jul;
[PubMed PMID: 26088071]
Level 3 (low-level) evidence
[49]
Modi PK, Kwon YS, Davis RB, Elsamra SE, Dombrovskiy V, Olweny EO. Pediatric hospitalizations for upper urinary tract calculi: Epidemiological and treatment trends in the United States, 2001-2014. Journal of pediatric urology. 2018 Feb:14(1):13.e1-13.e6. doi: 10.1016/j.jpurol.2017.09.001. Epub 2017 Sep 7
[PubMed PMID: 28966022]
Level 2 (mid-level) evidence
[50]
Abufaraj M, Xu T, Cao C, Waldhoer T, Seitz C, D'andrea D, Siyam A, Tarawneh R, Fajkovic H, Schernhammer E, Yang L, Shariat SF. Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007-2018 Data. European urology focus. 2021 Nov:7(6):1468-1475. doi: 10.1016/j.euf.2020.08.011. Epub 2020 Sep 6
[PubMed PMID: 32900675]
Level 3 (low-level) evidence
[51]
Ferraro PM, Curhan GC, D'Addessi A, Gambaro G. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. Journal of nephrology. 2017 Apr:30(2):227-233. doi: 10.1007/s40620-016-0283-8. Epub 2016 Mar 11
[PubMed PMID: 26969574]
[52]
Wang K, Ge J, Han W, Wang D, Zhao Y, Shen Y, Chen J, Chen D, Wu J, Shen N, Zhu S, Xue B, Xu X. Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC urology. 2022 Apr 19:22(1):62. doi: 10.1186/s12894-022-01017-4. Epub 2022 Apr 19
[PubMed PMID: 35439979]
Level 1 (high-level) evidence
[53]
Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney international. 2005 Sep:68(3):1230-5
[PubMed PMID: 16105055]
[54]
Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. The Journal of urology. 2010 Jun:183(6):2244-8. doi: 10.1016/j.juro.2010.02.007. Epub 2010 Apr 18
[PubMed PMID: 20400141]
[55]
Madore F, Stampfer MJ, Rimm EB, Curhan GC. Nephrolithiasis and risk of hypertension. American journal of hypertension. 1998 Jan:11(1 Pt 1):46-53
[PubMed PMID: 9504449]
[56]
Madore F, Stampfer MJ, Willett WC, Speizer FE, Curhan GC. Nephrolithiasis and risk of hypertension in women. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1998 Nov:32(5):802-7
[PubMed PMID: 9820450]
[57]
Reiner AP, Kahn A, Eisner BH, Pletcher MJ, Sadetsky N, Williams OD, Polak JF, Jacobs DR Jr, Stoller ML. Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. The Journal of urology. 2011 Mar:185(3):920-5. doi: 10.1016/j.juro.2010.10.086. Epub 2011 Jan 19
[PubMed PMID: 21251678]
[58]
Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC. Kidney stones associate with increased risk for myocardial infarction. Journal of the American Society of Nephrology : JASN. 2010 Oct:21(10):1641-4. doi: 10.1681/ASN.2010030253. Epub 2010 Jul 8
[PubMed PMID: 20616170]
[59]
Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, Curhan GC, Tonelli M, Alberta Kidney Disease Network. Kidney stones and cardiovascular events: a cohort study. Clinical journal of the American Society of Nephrology : CJASN. 2014 Mar:9(3):506-12. doi: 10.2215/CJN.04960513. Epub 2013 Dec 5
[PubMed PMID: 24311706]
[60]
Chung SD, Liu SP, Keller JJ, Lin HC. Urinary calculi and an increased risk of stroke: a population-based follow-up study. BJU international. 2012 Dec:110(11 Pt C):E1053-9. doi: 10.1111/j.1464-410X.2012.11210.x. Epub 2012 May 15
[PubMed PMID: 22583934]
[61]
Liu Y, Li S, Zeng Z, Wang J, Xie L, Li T, He Y, Qin X, Zhao J. Kidney stones and cardiovascular risk: a meta-analysis of cohort studies. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014 Sep:64(3):402-10. doi: 10.1053/j.ajkd.2014.03.017. Epub 2014 May 5
[PubMed PMID: 24797522]
Level 1 (high-level) evidence
[62]
Shoag J, Halpern J, Goldfarb DS, Eisner BH. Risk of chronic and end stage kidney disease in patients with nephrolithiasis. The Journal of urology. 2014 Nov:192(5):1440-5. doi: 10.1016/j.juro.2014.05.117. Epub 2014 Jun 11
[PubMed PMID: 24929140]
[63]
Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN. 2009 Apr:4(4):804-11. doi: 10.2215/CJN.05811108. Epub 2009 Apr 1
[PubMed PMID: 19339425]
[64]
El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD. Urolithiasis and the risk of ESRD. Clinical journal of the American Society of Nephrology : CJASN. 2012 Sep:7(9):1409-15
[PubMed PMID: 22745275]
[65]
Rule AD, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clinical journal of the American Society of Nephrology : CJASN. 2011 Aug:6(8):2069-75. doi: 10.2215/CJN.10651110. Epub 2011 Jul 22
[PubMed PMID: 21784825]
[66]
Dhondup T, Kittanamongkolchai W, Vaughan LE, Mehta RA, Chhina JK, Enders FT, Hickson LJ, Lieske JC, Rule AD. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2018 Dec:72(6):790-797. doi: 10.1053/j.ajkd.2018.06.012. Epub 2018 Aug 23
[PubMed PMID: 30146423]
[67]
Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. Current opinion in nephrology and hypertension. 2013 Jul:22(4):390-6. doi: 10.1097/MNH.0b013e32836214b9. Epub
[PubMed PMID: 23736840]
Level 3 (low-level) evidence
[68]
Evan A, Lingeman J, Coe FL, Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney international. 2006 Apr:69(8):1313-8
[PubMed PMID: 16614720]
[69]
Edvardsson VO, Goldfarb DS, Lieske JC, Beara-Lasic L, Anglani F, Milliner DS, Palsson R. Hereditary causes of kidney stones and chronic kidney disease. Pediatric nephrology (Berlin, Germany). 2013 Oct:28(10):1923-42. doi: 10.1007/s00467-012-2329-z. Epub 2013 Jan 20
[PubMed PMID: 23334384]
[70]
Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Bataille P, Bridoux F, Brignon P, Choquenet C, Cochat P, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Noël C, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M, French Cystinuria Group. CKD and Its Risk Factors among Patients with Cystinuria. Clinical journal of the American Society of Nephrology : CJASN. 2015 May 7:10(5):842-51. doi: 10.2215/CJN.06680714. Epub 2015 Feb 25
[PubMed PMID: 25717071]
[71]
Eassa WA, Sheir KZ, Gad HM, Dawaba ME, El-Kenawy MR, Elkappany HA. Prospective study of the long-term effects of shock wave lithotripsy on renal function and blood pressure. The Journal of urology. 2008 Mar:179(3):964-8; discussion 968-9. doi: 10.1016/j.juro.2007.10.055. Epub 2008 Jan 22
[PubMed PMID: 18207167]
[72]
Denburg MR, Jemielita TO, Tasian GE, Haynes K, Mucksavage P, Shults J, Copelovitch L. Assessing the risk of incident hypertension and chronic kidney disease after exposure to shock wave lithotripsy and ureteroscopy. Kidney international. 2016 Jan:89(1):185-92. doi: 10.1038/ki.2015.321. Epub 2016 Jan 4
[PubMed PMID: 26509587]
[73]
Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proceedings of the National Academy of Sciences of the United States of America. 2008 Jul 15:105(28):9841-6. doi: 10.1073/pnas.0709652105. Epub 2008 Jul 14
[PubMed PMID: 18626008]
[74]
Stamatelou KK,Francis ME,Jones CA,Nyberg LM,Curhan GC, Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney international. 2003 May;
[PubMed PMID: 12675858]
[75]
Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Reviews in urology. 2010 Spring:12(2-3):e86-96
[PubMed PMID: 20811557]
[76]
Hyams ES, Matlaga BR. Economic impact of urinary stones. Translational andrology and urology. 2014 Sep:3(3):278-83. doi: 10.3978/j.issn.2223-4683.2014.07.02. Epub
[PubMed PMID: 26816777]
[77]
Wiener SV, Ho SP, Stoller ML. Beginnings of nephrolithiasis: insights into the past, present and future of Randall's plaque formation research. Current opinion in nephrology and hypertension. 2018 Jul:27(4):236-242. doi: 10.1097/MNH.0000000000000414. Epub
[PubMed PMID: 29697409]
Level 3 (low-level) evidence
[78]
Cohen AJ, Borofsky MS, Anderson BB, Dauw CA, Gillen DL, Gerber GS, Worcester EM, Coe FL, Lingeman JE. Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. Journal of endourology. 2017 Jan:31(1):85-90. doi: 10.1089/end.2016.0537. Epub 2016 Dec 20
[PubMed PMID: 27824271]
[79]
Siener R, Herwig H, Rüdy J, Schaefer RM, Lossin P, Hesse A. Urinary stone composition in Germany: results from 45,783 stone analyses. World journal of urology. 2022 Jul:40(7):1813-1820. doi: 10.1007/s00345-022-04060-w. Epub 2022 Jun 6
[PubMed PMID: 35666268]
[81]
Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney international. 2002 Sep:62(3):971-9
[PubMed PMID: 12164880]
[82]
Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius HG. Kidney stones. Nature reviews. Disease primers. 2016 Feb 25:2():16008. doi: 10.1038/nrdp.2016.8. Epub 2016 Feb 25
[PubMed PMID: 27188687]
[83]
Jaffer A, Joyce A, Koenig P, Biyani CS. Adenine Phosphoribosyltransferase Deficiency: A Rare Cause of Recurrent Urolithiasis. Journal of endourology case reports. 2017:3(1):49-51. doi: 10.1089/cren.2017.0015. Epub 2017 Apr 1
[PubMed PMID: 28466077]
Level 3 (low-level) evidence
[84]
Song Y, Zhao C, Li D. Research progress on renal calculus associate with inborn error of metabolism. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences. 2023 Apr 25:52(2):169-177. doi: 10.3724/zdxbyxb-2022-0698. Epub
[PubMed PMID: 37283101]
[86]
Vall-Palomar M, Madariaga L, Ariceta G. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatric nephrology (Berlin, Germany). 2021 Oct:36(10):3045-3055. doi: 10.1007/s00467-021-04968-2. Epub 2021 Feb 17
[PubMed PMID: 33595712]
[87]
Bergwitz C, Miyamoto KI. Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy. Pflugers Archiv : European journal of physiology. 2019 Jan:471(1):149-163. doi: 10.1007/s00424-018-2184-2. Epub 2018 Aug 14
[PubMed PMID: 30109410]
[88]
Kubihal S, Goyal A, Singla R, Khadgawat R. Urolithiasis due to Hereditary Xanthinuria Type II: A Long-term Follow-up report. Indian pediatrics. 2020 May 15:57(5):468-469
[PubMed PMID: 32444521]
[90]
Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, Milliner DS, Harris PC, Sas DJ, Lieske JC. Primary Hyperoxaluria Type 3. GeneReviews(®). 1993:():
[PubMed PMID: 26401545]
[91]
Groothoff JW, Metry E, Deesker L, Garrelfs S, Acquaviva C, Almardini R, Beck BB, Boyer O, Cerkauskiene R, Ferraro PM, Groen LA, Gupta A, Knebelmann B, Mandrile G, Moochhala SS, Prytula A, Putnik J, Rumsby G, Soliman NA, Somani B, Bacchetta J. Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope. Nature reviews. Nephrology. 2023 Mar:19(3):194-211. doi: 10.1038/s41581-022-00661-1. Epub 2023 Jan 5
[PubMed PMID: 36604599]
Level 3 (low-level) evidence
[92]
Coe FL, Evan A, Worcester E. Kidney stone disease. The Journal of clinical investigation. 2005 Oct:115(10):2598-608
[PubMed PMID: 16200192]
[96]
Sandhu MS, Gulati A, Saritha J, Nayak B. Urolithiasis: Comparison of diagnostic performance of digital tomosynthesis and ultrasound. Which one to choose and when? European journal of radiology. 2018 Aug:105():25-31. doi: 10.1016/j.ejrad.2018.05.017. Epub 2018 May 17
[PubMed PMID: 30017289]
[97]
Kaul I, Moore S, Barry E, Pareek G. Renal Imaging in Stone Disease: Which Modality to Choose? Rhode Island medical journal (2013). 2023 Dec 1:106(11):31-35
[PubMed PMID: 38015782]
[98]
Brisbane W, Bailey MR, Sorensen MD. An overview of kidney stone imaging techniques. Nature reviews. Urology. 2016 Nov:13(11):654-662. doi: 10.1038/nrurol.2016.154. Epub 2016 Aug 31
[PubMed PMID: 27578040]
Level 3 (low-level) evidence
[99]
Erbay G, Yalcın A, Gultekin MH. Predictor Role of Pretreatment Resistive and Pulsatile Indexes in the Success of Medical Expulsive Therapy of Ureteral Stones. Urology. 2018 Aug:118():47-51. doi: 10.1016/j.urology.2018.04.020. Epub 2018 May 2
[PubMed PMID: 29729361]
[100]
Batura D, Hashemzehi T, Gayed W. Should contrast CT urography replace non-contrast CT as an investigation for ureteric colic in the emergency department in those aged 65 and over? Emergency radiology. 2018 Dec:25(6):621-626. doi: 10.1007/s10140-018-1620-0. Epub 2018 Jun 27
[PubMed PMID: 29946802]
[101]
Rodger F, Roditi G, Aboumarzouk OM. Diagnostic Accuracy of Low and Ultra-Low Dose CT for Identification of Urinary Tract Stones: A Systematic Review. Urologia internationalis. 2018:100(4):375-385. doi: 10.1159/000488062. Epub 2018 Apr 12
[PubMed PMID: 29649823]
Level 1 (high-level) evidence
[102]
Kennish SJ, Wah TM, Irving HC. Unenhanced CT for the evaluation of acute ureteric colic: the essential pictorial guide. Postgraduate medical journal. 2010 Jul:86(1017):428-36. doi: 10.1136/pgmj.2009.084954. Epub
[PubMed PMID: 20634253]
[103]
Dalla Palma L, Pozzi-Mucelli R, Stacul F. Present-day imaging of patients with renal colic. European radiology. 2001:11(1):4-17
[PubMed PMID: 11194915]
[104]
Pfister SA, Deckart A, Laschke S, Dellas S, Otto U, Buitrago C, Roth J, Wiesner W, Bongartz G, Gasser TC. Unenhanced helical computed tomography vs intravenous urography in patients with acute flank pain: accuracy and economic impact in a randomized prospective trial. European radiology. 2003 Nov:13(11):2513-20
[PubMed PMID: 12898174]
Level 1 (high-level) evidence
[105]
Patel VA, Popat NP. Essentials of Computed Tomography Imaging of Hematuria. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2023 Jan 1:34(1):61-79. doi: 10.4103/1319-2442.391003. Epub 2023 Dec 12
[PubMed PMID: 38092717]
[106]
Khandelwal S, Dhande R, Sood A, Parihar P, Mishra GV. Role of Multidetector Computed Tomography Urography in the Evaluation of Obstructive Uropathy: A Review. Cureus. 2023 Oct:15(10):e48038. doi: 10.7759/cureus.48038. Epub 2023 Oct 31
[PubMed PMID: 38034148]
[107]
Güven S, Sönmez MG, Somani BK, Gözen AS, Sarica K, Rivas JG, Nagele U, Tokas T. Current management of renal colic across Europe and its compliance to the European Association of Urology Guidelines on Urolithiasis: a survey from the European Section of Uro-technology, European Section of Urolithiasis, Young Academic Urologists study groups. Central European journal of urology. 2022:75(2):182-190. doi: 10.5173/ceju.2022.0046. Epub 2022 May 5
[PubMed PMID: 35937652]
Level 3 (low-level) evidence
[108]
Gnyawali D, Pradhan MM, Sigdel PR, Parajuli P, Chudal S, Poudyal S, Chapagain S, Luitel BR, Chalise PR, Sharma U, Gyawali PR. Efficacy of Tamsulosin plus Tadalafil versus Tamsulosin as Medical Expulsive Therapy for Lower Ureteric Stones: A Randomized Controlled Trial. Advances in urology. 2020:2020():4347598. doi: 10.1155/2020/4347598. Epub 2020 Jan 29
[PubMed PMID: 32411212]
Level 1 (high-level) evidence
[109]
Talebi Doluee M, Shams A, Keshvari Shirvan M, DadgarMoghadam M, Sadrzadeh SM, VafadarMoradi E. Renal Colic Pain Management by Tamsulosin with Morphine Versus Morphine in Adults: A Randomized Clinical Trial. Anesthesiology and pain medicine. 2023 Apr:13(2):e134627. doi: 10.5812/aapm-134627. Epub 2023 Apr 10
[PubMed PMID: 37601962]
Level 1 (high-level) evidence
[110]
Ye Z, Zeng G, Yang H, Tang K, Zhang X, Li H, Li W, Wu Z, Chen L, Chen X, Liu X, Deng Y, Pan T, Xing J, Wang S, Cheng Y, Gu X, Gao W, Yang J, Zhang Y, Mi Q, Qi L, Li J, Hu W, Liang P, Sun Z, Xu C, Long Y, Liao Y, Liu S, Liu G, Xu X, He W, Chen Z, Xu H. Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. European urology. 2018 Mar:73(3):385-391. doi: 10.1016/j.eururo.2017.10.033. Epub 2017 Nov 12
[PubMed PMID: 29137830]
Level 1 (high-level) evidence
[111]
Cui Y, Chen J, Zeng F, Liu P, Hu J, Li H, Li C, Cheng X, Chen M, Li Y, Li Y, Yang Z, Chen Z, Chand H, Chen H, Zu X. Tamsulosin as a Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of urology. 2019 May:201(5):950-955. doi: 10.1097/JU.0000000000000029. Epub
[PubMed PMID: 30694932]
Level 1 (high-level) evidence
[112]
Morsy S, Nasser I, Aboulela W, Abdelazim MS, Ali H. Efficacy of Mirabegron as Medical Expulsive Therapy for Distal Ureteral Stones: A Prospective, Randomized, Double-Blinded, Controlled Study. Urologia internationalis. 2022:106(12):1265-1271. doi: 10.1159/000521171. Epub 2022 Jan 31
[PubMed PMID: 35100594]
Level 1 (high-level) evidence
[113]
Tang QL, Wang DJ, Zhou S, Tao RZ. Mirabegron in medical expulsive therapy for distal ureteral stones: a prospective, randomized, controlled study. World journal of urology. 2021 Dec:39(12):4465-4470. doi: 10.1007/s00345-021-03772-9. Epub 2021 Jul 9
[PubMed PMID: 34241685]
Level 1 (high-level) evidence
[114]
Abdel-Kader MS, Sayed AM, Sayed SM, AbdelRazek M. Evaluation of the efficacy and safety of either or both mirabegron and silodosin, as a medical expulsive therapy for distal ureteric stones. International urology and nephrology. 2024 May:56(5):1605-1610. doi: 10.1007/s11255-023-03880-y. Epub 2023 Dec 2
[PubMed PMID: 38041752]
[115]
Yildirim K, Olcucu MT, Colak ME. Trends in the treatment of urinary stone disease in Turkey. PeerJ. 2018:6():e5390. doi: 10.7717/peerj.5390. Epub 2018 Jul 31
[PubMed PMID: 30083475]
[116]
Fedrigon DC, Jain R, Sivalingam S. Current use of medical expulsive therapy among endourologists. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2018 Sep:12(9):E384-E390. doi: 10.5489/cuaj.4978. Epub
[PubMed PMID: 29787372]
[117]
Diri A, Diri B. Management of staghorn renal stones. Renal failure. 2018 Nov:40(1):357-362. doi: 10.1080/0886022X.2018.1459306. Epub
[PubMed PMID: 29658394]
[119]
Almeras C, Abid N, Meria P, lithiasis committee of the French Association of Urology (CLAFU). 2022 Recommendations of the AFU Lithiasis Committee: Extracorporeal shock wave lithotripsy (ESWL). Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2023 Nov:33(14):812-824. doi: 10.1016/j.purol.2023.08.011. Epub
[PubMed PMID: 37918981]
[120]
Manukian MV. [Probability of development of "steinstrasse" depending on the number of extracorporeal shock wave lithotripsy in ureteral stones]. Georgian medical news. 2010 Apr:(181):13-7
[PubMed PMID: 20495220]
[122]
Raynal G, Malval B, Panthier F, Roustan FR, Traxer O, Meria P, Almeras C, lithiasis committee of the French Association of Urology (CLAFU). 2022 Recommendations of the AFU Lithiasis Committee: Ureteroscopy and ureterorenoscopy. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2023 Nov:33(14):843-853. doi: 10.1016/j.purol.2023.08.016. Epub
[PubMed PMID: 37918983]
[123]
Ibrahim A, Wollin D, Preminger G, Andonian S. Technique of Percutaneous Nephrolithotomy. Journal of endourology. 2018 May:32(S1):S17-S27. doi: 10.1089/end.2018.0047. Epub
[PubMed PMID: 29774824]
[124]
Abid N, Conort P, Franquet Q, Roustan FR, Meria P, Almeras C, Lithiasis Committee of the French Association of Urology (CLAFU). 2022 Recommendations of the AFU Lithiasis Committee: Percutaneous nephrolithotomy. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2023 Nov:33(14):854-863. doi: 10.1016/j.purol.2023.08.010. Epub
[PubMed PMID: 37918984]
[125]
Estrade V, Meria P, Almeras C, Lithiasis Committee of the French Association of Urology (CLAFU). 2022 Recommendations of the AFU Lithiasis Committee: Combined approach for the management of kidney and ureteral stones (Endoscopic Combined IntraRenal Surgery, ECIRS). Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2023 Nov:33(14):871-874. doi: 10.1016/j.purol.2023.08.009. Epub
[PubMed PMID: 37918986]
[126]
Sellers J, George A, Camacho J, Cammack JT, Medway A. Robotic-assisted laparoscopic pyelolithotomy with intracorporeal pyeloscopy in a horseshoe kidney. Urology case reports. 2023 Jan:46():102305. doi: 10.1016/j.eucr.2022.102305. Epub 2022 Dec 16
[PubMed PMID: 36590647]
Level 3 (low-level) evidence
[127]
Yeh YJ, Weng SC, Lin YH, Chen CL, Tsao SH, Tsai HY, Juang HH, Chang PL, Hou CP. Comparative Analysis of Surgical Outcomes of Flexible Ureteroscopy and Da Vinci Robotic Surgery in Community Patients with Renal Pelvic Stones Larger than 2 cm. Medicina (Kaunas, Lithuania). 2023 Jul 29:59(8):. doi: 10.3390/medicina59081395. Epub 2023 Jul 29
[PubMed PMID: 37629685]
Level 2 (mid-level) evidence
[128]
Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR, American Urological Assocation. Medical management of kidney stones: AUA guideline. The Journal of urology. 2014 Aug:192(2):316-24. doi: 10.1016/j.juro.2014.05.006. Epub 2014 May 20
[PubMed PMID: 24857648]
[129]
Amaro CR, Goldberg J, Damasio PC, Leitão VA, Turney B, Padovani CR, Amaro JL. An update on metabolic assessment in patients with urinary lithiasis. World journal of urology. 2015 Jan:33(1):125-9. doi: 10.1007/s00345-014-1271-z. Epub 2014 Mar 13
[PubMed PMID: 24623379]
[130]
Leslie SW, Sajjad H, Bashir K. 24-Hour Urine Testing for Nephrolithiasis: Interpretation and Treatment Guidelines. StatPearls. 2024 Jan:():
[PubMed PMID: 29494055]
[131]
Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, Türk C. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. European urology. 2015 Apr:67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20
[PubMed PMID: 25454613]
[132]
Vale L, Ribeiro AM, Costa D, Morgado A, Antunes-Lopes T, Dinis P, Silva C, Pacheco-Figueiredo L. Metabolic evaluation in urolithiasis - study of the prevalence of metabolic abnormalities in a tertiary centre. Central European journal of urology. 2020:73(1):55-61. doi: 10.5173/ceju.2020.0051. Epub 2020 Feb 25
[PubMed PMID: 32395325]
[133]
Courbebaisse M, Travers S, Bouderlique E, Michon-Colin A, Daudon M, De Mul A, Poli L, Baron S, Prot-Bertoye C. Hydration for Adult Patients with Nephrolithiasis: Specificities and Current Recommendations. Nutrients. 2023 Nov 22:15(23):. doi: 10.3390/nu15234885. Epub 2023 Nov 22
[PubMed PMID: 38068743]
[134]
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. The Journal of urology. 2016 Oct:196(4):1153-60. doi: 10.1016/j.juro.2016.05.090. Epub 2016 May 27
[PubMed PMID: 27238616]
[135]
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II. The Journal of urology. 2016 Oct:196(4):1161-9. doi: 10.1016/j.juro.2016.05.091. Epub 2016 May 27
[PubMed PMID: 27238615]
[136]
Morgan MS, Pearle MS. Medical management of renal stones. BMJ (Clinical research ed.). 2016 Mar 14:352():i52. doi: 10.1136/bmj.i52. Epub 2016 Mar 14
[PubMed PMID: 26977089]
[141]
Segall M, Mousavi A, Eisner BH, Scotland K. Pharmacologic treatment of kidney stones: Current medication and pH monitoring. Actas urologicas espanolas. 2024 Jan-Feb:48(1):11-18. doi: 10.1016/j.acuroe.2023.11.008. Epub 2023 Dec 1
[PubMed PMID: 38043680]
[142]
Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. The Journal of urology. 2003 Feb:169(2):465-9
[PubMed PMID: 12544288]
[143]
Pak CY, Fuller C, Sakhaee K, Preminger GM, Britton F. Long-term treatment of calcium nephrolithiasis with potassium citrate. The Journal of urology. 1985 Jul:134(1):11-9
[PubMed PMID: 3892044]
[144]
Park SM, Jee J, Joung JY, Cho YY, Sohn SY, Jin SM, Hur KY, Kim JH, Kim SW, Chung JH, Lee MK, Min YK. High Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium Excretion and Bone Resorption Marker. Journal of bone metabolism. 2014 Aug:21(3):189-94. doi: 10.11005/jbm.2014.21.3.189. Epub 2014 Aug 31
[PubMed PMID: 25247156]
[145]
Ong A, Brown G, Tokas T, Hameed BMZ, Philip J, Somani BK. Selection and Outcomes for Dissolution Therapy in Uric Acid Stones: A Systematic Review of Literature. Current urology reports. 2023 Aug:24(8):355-363. doi: 10.1007/s11934-023-01164-7. Epub 2023 Apr 20
[PubMed PMID: 37079196]
Level 1 (high-level) evidence
[146]
Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. The New England journal of medicine. 1984 Sep 20:311(12):760-4
[PubMed PMID: 6472365]
Level 1 (high-level) evidence
[147]
Gonzalez RD, Whiting BM, Canales BK. The history of kidney stone dissolution therapy: 50 years of optimism and frustration with renacidin. Journal of endourology. 2012 Feb:26(2):110-8. doi: 10.1089/end.2011.0380. Epub 2011 Oct 14
[PubMed PMID: 21999455]
[148]
Schillebeeckx C,Vander Eeckt K,Ost D,Van den Branden M,Deconinck S, Kidney Stone Dissolution Therapy in Phosphate Stones: A Case Report. Journal of endourology case reports. 2020;
[PubMed PMID: 32775674]
Level 3 (low-level) evidence
[149]
Øbro LF, Sloth Osther S, Osther PJS, Jung H. Case of the month from Lillebaelt hospital, University Hospital of South Denmark, Denmark: Renacidin(®) - still a useful adjunct to endoscopic surgery for complex renal struvite stone disease. BJU international. 2022 Oct:130(4):437-440. doi: 10.1111/bju.15822. Epub
[PubMed PMID: 36102583]
Level 3 (low-level) evidence
[150]
Wall I, Tiselius HG, Larsson L. Hemiacidrin: a useful component in the treatment of infectious renal stones. European urology. 1988:15(1-2):26-30
[PubMed PMID: 3215233]
[151]
Kachrilas S, Papatsoris A, Bach C, Bourdoumis A, Zaman F, Masood J, Buchholz N. The current role of percutaneous chemolysis in the management of urolithiasis: review and results. Urolithiasis. 2013 Aug:41(4):323-6. doi: 10.1007/s00240-013-0575-6. Epub 2013 Jun 7
[PubMed PMID: 23743991]
[152]
Taylor EN, Curhan GC. Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones. The Journal of urology. 2013 Oct:190(4):1255-9. doi: 10.1016/j.juro.2013.03.074. Epub 2013 Mar 25
[PubMed PMID: 23535174]
[153]
Chewcharat A, Thongprayoon C, Vaughan LE, Mehta RA, Schulte PJ, O'Connor HM, Lieske JC, Taylor EN, Rule AD. Dietary Risk Factors for Incident and Recurrent Symptomatic Kidney Stones. Mayo Clinic proceedings. 2022 Aug:97(8):1437-1448. doi: 10.1016/j.mayocp.2022.04.016. Epub 2022 Aug 1
[PubMed PMID: 35933132]
[154]
Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. Journal of the American Society of Nephrology : JASN. 2004 Dec:15(12):3225-32
[PubMed PMID: 15579526]
[155]
Knight J, Madduma-Liyanage K, Mobley JA, Assimos DG, Holmes RP. Ascorbic acid intake and oxalate synthesis. Urolithiasis. 2016 Aug:44(4):289-97. doi: 10.1007/s00240-016-0868-7. Epub 2016 Mar 22
[PubMed PMID: 27002809]
[156]
Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS. Effect of ascorbic acid consumption on urinary stone risk factors. The Journal of urology. 2003 Aug:170(2 Pt 1):397-401
[PubMed PMID: 12853784]
[157]
Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA internal medicine. 2013 Mar 11:173(5):386-8. doi: 10.1001/jamainternmed.2013.2296. Epub
[PubMed PMID: 23381591]
[159]
Reynolds LF, Kroczak T, Pace KT. Indications and contraindications for shock wave lithotripsy and how to improve outcomes. Asian journal of urology. 2018 Oct:5(4):256-263. doi: 10.1016/j.ajur.2018.08.006. Epub 2018 Sep 4
[PubMed PMID: 30364729]
[160]
Li X, Zhu W, Lam W, Yue Y, Duan H, Zeng G. Outcomes of long-term follow-up of asymptomatic renal stones and prediction of stone-related events. BJU international. 2019 Mar:123(3):485-492. doi: 10.1111/bju.14565. Epub 2018 Oct 22
[PubMed PMID: 30253029]